to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Beth Seidenberg, partner at venture firm Kleiner Perkins Caufield &amp; Byers, speaks at length about KPCB's current areas of interest, and its litmus test for projects worth supporting. Seidenberg also offers a case study of a life sciences firm moving from research lab toward market.
Tina Seelig is the Executive Director for the Stanford Technology Ventures Program where she is responsible for the management, operations, and dissemination efforts of STVP. In addition, Tina is the Director of the
Stanford Entrepreneurship Network and the co-Director of the Mayfield Fellows Program. Tina also teaches a course in the Department of Management Science & Engineering on Creativity and Innovation. Prior to joining STVP, Tina worked as
an entrepreneur, management consultant, author, and scientist. Tina received her Ph.D. from Stanford University Medical School in 1985 where she studied Neuroscience. Tina has worked as management consultant for Booz, Allen, and Hamilton,
has written several popular science books and has designed a series of educational games. Her books include The Epicurean Laboratory, Incredible Edible Science, and a series called Games for Your Brain. After Tina's first book was
published in 1991, she became interested in how books are marketed. This led her to start a company designed to help match books with buyers. The product was a multimedia system for bookstore customers, called BookBrowser. BookBrowser was
a kiosk-based system that allowed customers to identify books of interest. With the help of a team of engineers and graphic designers, Tina built the business and sold the company in 1993. After selling her business, Tina worked as a
Multimedia Producer for Compaq Computer Corporation. In this position Tina led a team of engineers, artists, scriptwriters, and education specialists through the design and implementation of a series of multimedia titles. Tina's current
position as Executive Director of the Stanford Technology Ventures Program takes advantage of her technical background, in addition to her experiences as a manager, entrepreneur, and educator.
Thriving entrepreneurial hot spots do not just pop up overnight. It takes more than a few growing startups to turn a city intro a hub of entrepreneurial activity. This thought is confirmed by a new Kauffman Foundation white paper entitled “Path-Dependent Startup Hubs – Comparing Metropolitan Performance: High-Tech and ICT Startup Density”.
Even with the most intuitive educational material, sometimes the most important thing a students needs is the ability to ask questions. For entrepreneurs, who are often lifelong learners, this is essential to the application of the material to their business. While online learning can facilitate opportunities to learn lessons anytime, anywhere that might not otherwise be available, the opportunity to engage directly with experts creates important connections and discussions.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.